Literature DB >> 25892953

Cerebral amyloid angiopathy: an important differential diagnosis of stroke in the elderly.

Shahrul Azmin1, Syazarina Sharis Osman2, Shahizon Mukari2, Ramesh Sahathevan1.   

Abstract

Cerebral amyloid angiopathy (CAA) accounts for approximately 10-20% of spontaneous intracerebral haemorrhage (ICH). This figure is thought to be higher in the elderly population. With the increasing life expectancy of our population, we anticipate that the prevalence of CAA- related ICH will increase in tandem. Although CAA-related ICH and hypertension-related ICH are distinct entities based on histopathology and imaging, the clinical presentation of the two conditions is similar. The use of brain computed tomography (CT) scans remain the ICH imaging modality of choice in Malaysia due to its availability, cost, and sensitivity in detecting acute bleeds. On the other hand, the use of brain magnetic resonance imaging (MRI) with susceptibility-weighted imaging (SWI) sequencing enables the clinician to determine the presence of chronic blood products in the brain, especially clinically silent microbleeds associated with CAA. However, the use of brain MRI scans in our country is limited and leads to a blurring of lines when differentiating between hypertension-related ICH and CAA-related ICH. How this misrepresentation affects the management of these conditions is unclear. In this study, we present two cases of ICH to illustrate this point and to serve as a springboard to question current practice and promote discussion.

Entities:  

Keywords:  cerebral amyloid angiopathy; intracerebral haemorrhage; magnetic resonance imaging; stroke

Year:  2015        PMID: 25892953      PMCID: PMC4390777     

Source DB:  PubMed          Journal:  Malays J Med Sci        ISSN: 1394-195X


  13 in total

1.  Midlife blood pressure and dementia: the Honolulu-Asia aging study.

Authors:  L J Launer; G W Ross; H Petrovitch; K Masaki; D Foley; L R White; R J Havlik
Journal:  Neurobiol Aging       Date:  2000 Jan-Feb       Impact factor: 4.673

2.  Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.

Authors:  K A Knudsen; J Rosand; D Karluk; S M Greenberg
Journal:  Neurology       Date:  2001-02-27       Impact factor: 9.910

Review 3.  Cerebral amyloid angiopathy: CT and MR imaging findings.

Authors:  Christine P Chao; Amy L Kotsenas; Daniel F Broderick
Journal:  Radiographics       Date:  2006 Sep-Oct       Impact factor: 5.333

4.  Antiplatelet use after intracerebral hemorrhage.

Authors:  A Viswanathan; S M Rakich; C Engel; R Snider; J Rosand; S M Greenberg; E E Smith
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

5.  Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy.

Authors:  A Biffi; A Halpin; A Towfighi; A Gilson; K Busl; N Rost; E E Smith; M S Greenberg; J Rosand; A Viswanathan
Journal:  Neurology       Date:  2010-08-24       Impact factor: 9.910

6.  Is hypertension a more frequent risk factor for deep than for lobar supratentorial intracerebral haemorrhage?

Authors:  C A Jackson; C L M Sudlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-05-11       Impact factor: 10.154

7.  What are the causes of pre-existing dementia in patients with intracerebral haemorrhages?

Authors:  Charlotte Cordonnier; Didier Leys; Frédéric Dumont; Vincent Deramecourt; Régis Bordet; Florence Pasquier; Hilde Hénon
Journal:  Brain       Date:  2010-09-17       Impact factor: 13.501

8.  Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes.

Authors:  H V Vinters; J J Gilbert
Journal:  Stroke       Date:  1983 Nov-Dec       Impact factor: 7.914

9.  Descriptive analysis of the Boston criteria applied to a Dutch-type cerebral amyloid angiopathy population.

Authors:  Sanneke van Rooden; Jeroen van der Grond; Rivka van den Boom; Joost Haan; Jennifer Linn; Steven M Greenberg; Mark A van Buchem
Journal:  Stroke       Date:  2009-06-25       Impact factor: 7.914

10.  Cerebral amyloid angiopathy: a systematic review.

Authors:  Alessandro Biffi; Steven M Greenberg
Journal:  J Clin Neurol       Date:  2011-03-31       Impact factor: 3.077

View more
  1 in total

1.  Serum Neuropeptide Y: A Potential Prognostic Marker of Intracerebral Hemorrhage.

Authors:  Weiming Sun; Zhenxing Zhang; Xu Feng; Xin Sui; Ye Miao
Journal:  Dis Markers       Date:  2021-08-10       Impact factor: 3.434

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.